Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P2.02 - Biology/Pathology
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P2.02-001 - Detection of Gene Fusions in NSCLC Using NGS Fusion Assay
09:30 - 09:30 | Presenter: Yoon-La Choi | Author(s): M.E. Lira, Y.S. Choi, Seung Joon Kim, Y.M. Shim, O. Perez, Jhingook Kim
- Abstract
Loading... -
+
P2.02-002 - Digital Multiplexed Detection of Single Nucleotide Variants (SNV) in Non-Small Cell Lung Cancer Using NanoString Technology
09:30 - 09:30 | Presenter: Brielle Parris | Author(s): G. Meredith, P..M. Ross, M. Krouse, A. Mashadi-Hossein, R. Bowman, I. Yang, Kwun M Fong
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.02-005 - 13 Cases of Molecular Features Analysis in Pulmonary Mucoepidermoid Carcinoma
09:30 - 09:30 | Presenter: Gang Chen | Author(s): Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, Y. Chen, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.02-007 - Molecular Spectrum of STK11 Gene Mutations in Patients with Non-Small-Cell Lung Cancer in Chinese Patients
09:30 - 09:30 | Presenter: Gang Chen | Author(s): X. Chen, Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, Y. Zhu, Y. Chen, Rongrong Chen, Y. Guan, X. Yi, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.02-009 - Metabolomic Analysis in Lung Cancer
09:30 - 09:30 | Presenter: Naohiro Kajiwara | Author(s): S. Maehara, J. Maeda, M. Hagiwara, T. Okano, Masatoshi Kakihana, Tatsuo Ohira, M. Sugimoto, Norihiko Ikeda
- Abstract
Loading... -
+
P2.02-010 - Oncogenic Role of PKP1 in Non-Small-Cell Lung Cancer.
09:30 - 09:30 | Presenter: Pedro P Medina | Author(s): J. Martin-Padron, L. Boyero Corral, M.I. Rodriguez Lara, Á. Andrades Delgado, E. Farez-Vidal
- Abstract
Loading... -
+
P2.02-011 - Clinical and Molecular Features of Lung Cancers with Increased FGFR1 mRNA and/or Gene Copy Number
09:30 - 09:30 | Presenter: Terry L. Ng | Author(s): Hui Yu, E. York, S. Leedy, D. Gao, L. Heasley, Fred R. Hirsch, D. Ross Camidge
- Abstract
Loading... -
+
P2.02-012 - The Epigenetic Role of LSD1+8a in Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Aditya Wirawan | Author(s): K. Tajima, F. Takahashi, Moulid Hidayat, R. Kanemaru, Y. Koinuma, D. Hayakawa, M. Tajima, N. Matsumoto, K. Kanamori, I. Takeda, M. Kato, I. Kobayashi, N. Shimada, K. Takahashi
- Abstract
Loading... -
+
P2.02-013 - Investigation of Genomic and TCR Repertoire Evolution of AAH, AIS, MIA to Invasive Lung Adenocarcinoma by Multiregion Exome and TCR Sequencing
09:30 - 09:30 | Presenter: Jianjun Zhang | Author(s): X. Hu, J. Fujimoto, L. Ying, A. Reuben, R. Chen, C. Chow, J. Rodriguez-Canales, W. Sun, J. Hu, E.R. Parra, B. Carmen, C. Wu, X. Mao, X. Song, J. Li, C. Gumbs, S.G. Swisher, J. Zhang, John V Heymach, W.K. Hong, Ignacio I. Wistuba, A. Futreal, D. Su
- Abstract
Loading... -
+
P2.02-014 - Simultaneous Gene Profiling of Advanced NSCLC: Single-Molecule Quantification of DNA and RNA by nCounter3D™ Technology
09:30 - 09:30 | Presenter: Cristina Teixidó | Author(s): A. Giménez-Capitán, G. Meredith, D. Martinez, A. Mashadi-Hossein, C. Hernan, P..M. Ross, A. Arcocha, P. Galván, N. Vilariño, S. Lopez-Padres, S. Rodriguez, J. Bertran-Alamillo, A. Prat, Miguel-Angel Molina-Vila, Noemi Reguart
- Abstract
Loading... -
+
P2.02-015 - Mutation Patterns in a Swedish Non-Small Cell Lung Cancer Cohort
09:30 - 09:30 | Presenter: Linnea La Fleur | Author(s): E. Falk-Sörqvist, P. Smeds, Johanna Sofia Margareta Mattsson, M. Sundström, E. Branden, H. Koyi, J. Isaksson, H. Brunnström, M. Nilsson, Patrick Micke, L. Moens, J. Botling
- Abstract
Loading... -
+
P2.02-016 - Pulmonary Sarcomas: A Comprehensive Genomic Profiling Study
09:30 - 09:30 | Presenter: Jeffrey S. Ross | Author(s): J. Suh, Siraj M Ali, A.B. Schrock, J. Elvin, J. Vergilio, S. Ramkissoon, V.A. Miller, P.J. Stephens, L. Gay
- Abstract
Loading... -
+
P2.02-017 - Aberrant Expression of Long Non-Coding RNAs from Pseudogene Loci Highlights Alternative Mechanisms of Cancer Gene Regulation
09:30 - 09:30 | Presenter: Greg L. Stewart | Author(s): Katey S.S. Enfield, Victor D Martinez, Adam Patrick Sage, Erin Anne Marshall, Stephen Lam, W.L. Lam
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.02-019 - Utility of Circulating Tumor DNA (CtDNA) in Prognostication of Lung Cancer vs. Other Cancer Types
09:30 - 09:30 | Presenter: Francisco III Maramara Heralde | Author(s): Maria Teresa Alhambra Barzaga, N. Tan-Liu
- Abstract
Loading... -
+
P2.02-020 - Molecular Characteristics of Patients with PTEN Mutations in Chinese Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): Xiaobing Zheng, Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, Y. Zhu, Rongrong Chen, Y. Guan, X. Yi, Y. Chen, Gang Chen, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P2.02-021 - Prevalence of PTPRD Gene Mutations in Chinese Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): S. Wang, Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, Y. Zhu, Rongrong Chen, Y. Guan, X. Yi, Y. Chen, Gang Chen, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P2.02-022 - Alternative Regulation of Cancer-Associated Genes through Modulation of Long Non-Coding RNAs
09:30 - 09:30 | Presenter: Adam Patrick Sage | Author(s): Greg L. Stewart, C. Anderson, D.A. Rowbotham, Katey S.S. Enfield, Erin Anne Marshall, Victor D Martinez, W.L. Lam
- Abstract
Loading... -
+
P2.02-023 - Targeted Gene Expression Profiling to Evaluate Minimal Diagnostic FFPE-Biopsies from NSCLC-Patients
09:30 - 09:30 | Presenter: Johanna Sofia Margareta Mattsson | Author(s): Victor Pontén, M.W. Backman, Patrick Micke
- Abstract
Loading... -
+
P2.02-024 - False Positivity Due to Polysomy in Fluorescence in Situ Hybridization
09:30 - 09:30 | Presenter: Erik Thunnissen | Author(s): A.L. Görtz, Stephen P Finn, Lukas Bubendorf, I. Bahce, B. Witte
- Abstract
Loading... -
+
P2.02-025 - Histological Difference of Tumor-Infiltrate Lymphocytes in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Naohiro Kobayashi | Author(s): Shinji Kikuchi, Y. Goto, Y. Sato, S. Sakashita, M. Noguchi
- Abstract
Loading... -
+
P2.02-026 - Impact of PD-L1 Expression on 18F-FDG-PET in Pulmonary Squamous Cell Carcinoma
09:30 - 09:30 | Presenter: Norimitsu Kasahara | Author(s): K. Kaira, B. Alatan, T. Higuachi, Y. Arisaka, E. Bilguun, N. Sunaga, T. Oyama, T. Yokobori, T. Asao, M. Nishiyama, K. Shimizu, A. Mogi, H. Kuwano
- Abstract
Loading... -
+
P2.02-027 - Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
09:30 - 09:30 | Presenter: José Miguel Sánchez-Torres | Author(s): J. Rogado, M.D. Fenor De La Maza, V. Pacheco-Barcia, J.M. Serra, P. Toquero, B. Vera, A. Ballesteros, R. Mondéjar, O. Donnay, B. Obispo, R. Colomer
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.02-030 - Bavituximab in Combination With Nivolumab Enhances Tumor Immune Response in a 3D Ex Vivo System of Lung Cancer Patients
09:30 - 09:30 | Presenter: Joseph Shan | Author(s): M. Mediavilla-Varela, M.M. Page, J. Kreahling, B. Freimark, N.L. Kallinteris, S. Antonia, S. Altiok
- Abstract
Loading... -
+
P2.02-031 - Relationship between PD-L1 Expression and EGFR/HER2 Signaling in Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Riki Okita | Author(s): A. Maeda, Katsuhiko Shimizu, Y. Nojima, S. Saisho, M. Nakata
- Abstract
Loading... -
+
P2.02-032 - Interplaying between Gamma-H2AX and Autophagy in A549 Cells Treated with Cisplatin and Etoposide
09:30 - 09:30 | Presenter: Jong Wook Shin | Author(s): S.E. Lee
- Abstract
Loading... -
+
P2.02-033 - The Association of PD-L1 Expression with Clinical Characteristics and EGFR and ALK Status in Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Jinghui Wang | Author(s): S. Wu, Xiaohua Shi, Y. Liu, X. Zeng, L. Zhou
- Abstract
Loading... -
+
P2.02-034 - PD-L1 Expression Can Be a Prognostic Marker in EGFR Mutant NSCLC Patients Treated with Erlotinib
09:30 - 09:30 | Presenter: Niki Karachaliou | Author(s): Andrés F. Cardona, M. González Cao, A. Giménez-Capitán, A. Drozdowskyj, E. Aldeguer, G. López-Vivanco, José Miguel Sánchez-Torres, M. De Los Llanos Gil, Miguel-Angel Molina-Vila, Rafael Rosell
- Abstract
Loading... -
+
P2.02-035 - PD-L1 IHC Test on Cytological Cell Block Specimen; Potential Utility and Practical Issues
09:30 - 09:30 | Presenter: Michiko Sugiyama | Author(s): T. Hashimoto, K. Yoshida, Y. Shibuki, Shun-ichi Watanabe, N. Yamamoto, Yuichiro Ohe, N. Motoi
- Abstract
Loading... -
+
P2.02-036 - The Expression Pattern of CD26/DPP4 in Human Lung Cancer
09:30 - 09:30 | Presenter: Ignacio Gil-Bazo | Author(s): J. Jang, M. Haberecker, C. Alexandra, A. Soltermann, F. Janker, K. Kwon, Walter Weder, W. Jungraithmayr
- Abstract
Loading... -
+
P2.02-037 - CD14+ Cell Tumor Microenvironment Infiltration Correlates with Poor Overall Survival in Patients with Early Stage Lung Cancer
09:30 - 09:30 | Presenter: Erin Schenk | Author(s): J. Boland, S. Withers, P. Bulur, A. Dietz
- Abstract
Loading... -
+
P2.02-038 - Imaging Platform for the Quantification of Cell-Cell Spatial Organization within the Tumour-Immune Microenvironment
09:30 - 09:30 | Presenter: Katey S.S. Enfield | Author(s): S.D. Martin, Victor D Martinez, S.H.Y. Kung, P. Gallagher, K. Milne, Z. Chen, Stephen Lam, J.C. English, C.E. Macaulay, M. Guillaud, W.L. Lam
- Abstract
Loading... -
+
P2.02-039 - Spatial Heterogeneity of Immunological Markers Between Cores and Complete NSCLC Sections Using Multispectral Fluorescent IHC
09:30 - 09:30 | Presenter: Geoffrey Peters | Author(s): M. Ameratunga, D. Tutuka, M. Walkiewicz, Prudence Russell, S.R. Knight, P. Mitchell, T. John
- Abstract
Loading... -
+
P2.02-040 - Cytology Cell Block Is Suitable for Immunohistochemical Testing for PD-L1 in Lung Cancer
09:30 - 09:30 | Presenter: Hangjun Wang | Author(s): J. Agulnik, G. Kasymjanova, A.Y. Wang, V. Cohen, C. Pepe, D. Small, L. Sakr, P. Fiset, M. Auger, S. Camilleri-Broet, M. Alam Ei Din, A. Spatz
- Abstract
Loading... -
+
P2.02-041 - Update on Prospective Immunogenomic Profiling of Non-Small Cell Lung Cancer (ICON Project)
09:30 - 09:30 | Presenter: Jianjun Zhang | Author(s): B. Sepesi, I.P. Icon Team, Don Lynn Gibbons
- Abstract
Loading... -
+
P2.02-042 - Clinical Significance of the Tumor Expression of PD-L1 Using Four Immunohistochemistry Assays in Non-Small Cell Lung Cancer. Multicentre Study
09:30 - 09:30 | Presenter: Cristian Ortiz -Villalón | Author(s): A. Yoshikawa, L. Kis, A. Montero, Anja C Roden, H.H.N. Pham, C. Fernandez, J. Fukuoka, R. Lewensohn, L. De Petris
- Abstract
Loading... -
+
P2.02-043 - Multicentre Assessment of PD-L1 Immunohistochemistry: Challenges for Establishing the Concordance Between Four Different Antibodies
09:30 - 09:30 | Presenter: Cristian Ortiz -Villalón | Author(s): H.H.N. Pham, A. Yoshikawa, A. Montero, Anja C Roden, C. Fernandez, L. Kis, L. De Petris, J. Fukuoka
- Abstract
Loading... -
+
P2.02-044 - Pulmonary Findings in 7 Autopsy Cases of Patients Treated with Immune Checkpoint Inhibitors
09:30 - 09:30 | Presenter: Peter B Illei | Author(s): E.D. Thompson, J.M. Taube, J.E. Hooper, E. Rodriguez
- Abstract
Loading... -
+
P2.02-045 - PD-L1 Assessment in Cytology Samples
09:30 - 09:30 | Presenter: Peter B Illei | Author(s): A. Lerner, L. Yarmus
- Abstract
Loading... -
+
P2.02-046 - Assessment of PDL1 and Immunoprofiling Using Multiplex Quantitative Immunofluorescence in Lung Cancer: Clinical Implications
09:30 - 09:30 | Presenter: Vera Luiza Capelozzi | Author(s): Tabatha Gutierrez Prieto, C.A. Fahrat, T. Takagaki, J. Rodriguez-Canales, Ignacio I. Wistuba, E.R. Parra Cuentas
- Abstract
Loading... -
+
P2.02-047 - Comparison of PD-L1 Immunohistochemistry Assays and Response to PD-L1 Inhibitors
09:30 - 09:30 | Presenter: Sanja Dacic | Author(s): K. Ancevski, S. Aberrbock, C. Herbst, L. Villaruz
- Abstract
Loading... -
+
P2.02-048 - Survival Correlation Between TP53 Gene and PD-L1 Tumour Expression in Resected Non-Small Cell Lung Carcinoma
09:30 - 09:30 | Presenter: Jane Sze Yin Sui | Author(s): M.Y. Teo, S. Twomey, S. Rafee, J. McFadden, K. Gately, Martin P Barr, Steven G. Gray, B. Hennessy, Kenneth Obyrne, S. Cuffe, Stephen P Finn
- Abstract
Loading... -
+
P2.02-049 - Immunohistochemical Approach in Predicting Primary Lung Cancer Outcome: A Single Center Study
09:30 - 09:30 | Presenter: Gulrukh Komiljonovna Botiralieva | Author(s): M.N. Tillyashaykhov, A.A. Yusupbekov
- Abstract
Loading... -
+
P2.02-050 - Weighted Genes Co-expression Network Analysis of Lung Cancers Concerning Patients Overall Survival and Cancer Stage
09:30 - 09:30 | Presenter: Haolong Qi | Author(s): G.G. Chen
- Abstract
Loading... -
+
P2.02-051 - Bevacizumab Prevents Growth of Established Non-Small Cell Lung Cancer Brain Metastases in Hematogenous Brain Metastasis Model
09:30 - 09:30 | Presenter: Chinami Masuda | Author(s): M. Monnai, C. Ishimaru, R. Nakamura, M. Kinoshita, K. Yorozu, M. Kurasawa, M. Sugimoto, K. Yamamoto
- Abstract
Loading... -
+
P2.02-052 - A Clinically-Validated Universal Companion Diagnostic Platform for Cancer Patient Care
09:30 - 09:30 | Presenter: James Sun | Author(s): Y. Li, C. Milbury, J. Skoletsky, C. Burns, W. Yip, J. Luo, N. Dewal, A. Johnson, K. Gowen, J. Tong, Y. He, J. He, J. White, S. Roels, A. Tsuji, J. Truesdell, E. Peters, H. Gilbert, C. Wu, E. Schleifman, C. Barrett, K.S. Thress, S. Jenkins, J. Elvin, G. Otto, D. Lipson, Jeffrey S. Ross, V.A. Miller, P.J. Stephens, M. Doherty, C. Vietz
- Abstract
Loading... -
+
P2.02-053 - The Prognostic Value of 18 Circulating Markers of Inflammation, Endothelial Activation and
Extracellular Matrix Remodelling in Non-small Cell Lung Cancer Patients09:30 - 09:30 | Presenter: Janna Berg | Author(s): A.R. Halvorsen, M. Bengtson, K.A. Taskén, G. Mælandsmo, A. Yndestad, B. Halvorsen, O.T. Brustugun, P. Aukrust, T. Ueland, Å. Helland
- Abstract
Loading... -
+
P2.02-054 - Thymidylate Synthase Promotes Epithelial-To-Mesenchymal Transition and Aggressiveness in NSCLC
09:30 - 09:30 | Presenter: Paolo Ceppi | Author(s): A. Siddiqui, M.E. Vazakidou, A. Schwab, F. Napoli, I. Rapa, M. Volante, T. Brabletz
- Abstract
Loading... -
+
P2.02-055 - Stratifin Regulates Stabilization of Receptor Tyrosine Kinases via Activation of Ubiquitin-Specific Protease 8 in Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Aya Shiba | Author(s): Y. Kim, M. Noguchi
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.02-057 - Expression of MGAT4a and MGAT5 Are Correlated with Poorer Outcome in Advanced Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Yoko Nakanishi | Author(s): H. Nishimaki, I. Tsujino, N. Takahashi, M. Shimamura, H. Kobayashi, X.Y. Tang, Y. Kusumi, S. Hashimoto, S. Masuda
- Abstract
Loading... -
+
P2.02-058 - Endogenous Arginase 2 as a Biomarker for PEGylated Arginase 1 Treatment in Squamous Cell Lung Carcinoma Xenograft Models
09:30 - 09:30 | Presenter: Sze Kwan Lam | Author(s): Shi Xu, P.N. Cheng, J.C. Ho
- Abstract
Loading... -
+
P2.02-059 - Genomic Mutation Patterns Detected with Cancer Panel Can Predict Postoperative Prognosis in Clinical Stage I Adenocarcinoma
09:30 - 09:30 | Presenter: Kwanyong Hyun | Author(s): Y.J. Jung, S. Im, Y.H. Kim, S.B. Lee, S. Park, H.J. Lee, In Kyu Park, Chang Hyun Kang, Young Tae Kim
- Abstract
Loading... -
+
P2.02-060 - Prognostic Significance of EDIL3 Expression and Correlation with Mesenchymal Phenotype and Microvessel Density in Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Young Wha Koh | Author(s): D. Jeong
- Abstract
Loading... -
+
P2.02-061 - Two Novel Protein-Based Prognostic Signatures Improve Risk Stratification of Early Lung ADC and SCC Patients
09:30 - 09:30 | Presenter: Luis M Montuenga | Author(s): E. Martinez-Terroba, C. Behrens, F. De Miguel, J. Agorreta, Eduard Monsó, L. Millares, M. Mesa-Guzman, J.L. Perez-Gracia, M.D. Lozano, Javier J. Zulueta, Ruben Pio, Ignacio I. Wistuba, M.J. Pajares
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.02-063 - Oncogenic microRNAs Associated with Poor Prognosis Are Up-Regulated on the Amplicon in Squamous Cell Lung Carcinoma
09:30 - 09:30 | Presenter: Sana Yokoi | Author(s): E. Xia, S. Kanematsu, Y. Suenaga, Y. Moriya, I. Yoshino, T. Iizasa
- Abstract
Loading... -
+
P2.02-064 - A Novel 5-miR Signature Shows Potential as a Diagnostic Tool and as a Predictive Biomarker of Cisplatin Response in NSCLC
09:30 - 09:30 | Presenter: Martin P Barr | Author(s): L. Mac Donagh, Steven G. Gray, M. Gallagher, B. Ffrench, C. Gasch, V. Young, R. Ryan, S. Nicholson, N. Leonard, Stephen P Finn, S. Cuffe, Kenneth Obyrne
- Abstract
Loading... -
+
P2.02-065 - RanBP9 is a Novel Prognostic and Predictive Biomarker for NSCLC and Affects Cellular Response to Cisplatin and PARP Inhibitors
09:30 - 09:30 | Presenter: Anna Tessari | Author(s): D. Palmieri, M. Pawlikowski, K. Parbhoo, C. Foray, M. Fassan, K. La Perle, E. Rulli, A. Fabbri, M. Ganzinelli, V. Embrione, M. Broggini, J.M. Amann, David P Carbone, Marina Chiara Garassino, C.M. Croce, V. Coppola
- Abstract
Loading... -
+
P2.02-066 - Identification of Crucial Gene Targets in the in Situ Environment of Cancer by Google Network Ranking
09:30 - 09:30 | Presenter: Victor Pontén | Author(s): M.W. Backman, Johanna Sofia Margareta Mattsson, Dijana Djureinovic, Patrick Micke
- Abstract
Loading... -
+
P2.02-067 - LKB1 Loss Is Associated with DNA Hypomethylation in Human Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Michael John Koenig | Author(s): J.M. Amann, C. Oakes, J.M. Kaufman, David P Carbone
- Abstract
Loading... -
+
P2.02-068 - BRG1 and p53 Expression in Resected Stage I – III Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Gwyn Bebb | Author(s): A.A. Elegbede, M. Koebel, A. D'Silva, M. Dean, E. Enwere, R.A. Tudor, A.J.W. Gibson, H. Li, S. Otsuka
- Abstract
Loading... -
+
P2.02-069 - Targeting Neuropilin-1 in NSCLC
09:30 - 09:30 | Presenter: Martin P Barr | Author(s): G. Pidgeon, Steven G. Gray, K. Gately, E. Hams, P.G. Fallon, S. Cuffe, Stephen P Finn, Kenneth Obyrne
- Abstract
Loading... -
+
P2.02-070 - C-MET as a Biomarker in Patients with Surgically Resected Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Georgios Tsakonas | Author(s): Fred R. Hirsch, S. Ekman
- Abstract
Loading... -
+
P2.02-071 - Prospective Molecular Study of 22 Genes by NGS in Patients with Non-Small Cell Lung Cancer (NSCLC) in Argentina: A Single Institution Experience
09:30 - 09:30 | Presenter: Valeria Cecilia Denninghoff | Author(s): G.J. Recondo, M.T. Cuello, V. Romano, V. Wainsztein, F. Galanternik, M. Greco, M. De La Vega, M.A. Avagnina, G. Recondo
- Abstract
Loading... -
+
P2.02-072 - Reliability of Small Biopsy Samples for Tumor PD-L1 Expression in Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Akihito Tsunoda | Author(s): K. Morikawa, M. Okamoto, T. Inoue, H. Kida, N. Furuya, H. Handa, H. Nishine, T. Inoue, T. Miyazawa, M. Mineshita
- Abstract
Loading... -
+
P2.02-073 - Cytoplasmic Mislocalization of ECT2 Protein Is Associated with Poor Prognosis in Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Zeinab Kosibaty | Author(s): Y. Murata, Yuko Minami, S. Sakashita, M. Noguchi
- Abstract
Loading... -
+
P2.02-073a - Does the PD-L1 Status and TIL Intensity Change in NSCLC and Syncronous Brain Metastases?
09:30 - 09:30 | Presenter: Buge Oz | Author(s): S. Durak, S. Batur, Perran Fulden Yumuk, H.B. Caglar, E. Bozkurtlar, S. Bozkurt, E. Tastekin, I. Cicin, R. Ahıskalı, R. Rzazade, A. Cakır
- Abstract
Loading... -
+
P2.02-073b - Genetic Profile in NSCLC Biopsy Samples. A Muticenter Local Study
09:30 - 09:30 | Presenter: Norma Pilnik | Author(s): V. Bengio, M. Canigiani, P. Diaz
- Abstract
Loading...
-
+
P2.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P2.03-001 - Survivors and Adverse Events After First-Line Target Therapy for Advanced Non-Small Cell Lung Cancer Patients in Taiwan
09:30 - 09:30 | Presenter: Lin Zhi Xuan | Author(s): C. Shu-Chan, H. Wen-Tsung
- Abstract
Loading... -
+
P2.03-002 - Impact of EGFR-Tyrosine Kinase Inhibitors for Postoperative Recurrent Non-Small Cell Lung Cancer Harboring EGFR Mutations
09:30 - 09:30 | Presenter: Satoshi Igawa | Author(s): Y. Sato, S. Kusuhara, S. Harada, M. Shirasawa, S. Kurahayashi, Y. Okuma, A. Sugimoto, K. Sugita, Y. Nakahara, S. Otani, T. Fukui, M. Yokoba, H. Mitsufuji, M. Kubota, M. Katagiri, J. Sasaki, N. Masuda
- Abstract
Loading... -
+
P2.03-003 - Cost Effectiveness of Gefitinib for Lung Adenocarcinoma Patients with Mutant Epidermal Growth Factor Receptor
09:30 - 09:30 | Presenter: Chun-Ru Chien | Author(s): T. Hsia, Chih-Yen Tu, H. Chen, S. Chen, C. Chen, W. Liao, C. Li, C. Lin, C. Li
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.03-005 - Overall Survival Results from a Prospective, Multicenter Phase II Trial of Low-Dose Erlotinib as Maintenance in NSCLC Harboring EGFR Mutation
09:30 - 09:30 | Presenter: Satoshi Hirano | Author(s): G. Naka, Y. Takeda, M. Iikura, T. Hiroishi, K. Shikano, A. Yanagisawa, N. Hayama, T. Fujita, H. Amano, M. Nakamura, S. Nakamura, H. Tabeta, H. Sugiyama
- Abstract
Loading... -
+
P2.03-006 - How Many Years of Life Have We Lost in Brazil Due to the Lack of Access to Anti-EGFR TKIs in the National Public Health System?
09:30 - 09:30 | Presenter: Pedro Aguiar Jr | Author(s): F. Roitberg, H. Tadokoro, R.A. De Mello, A. Del Giglio, Gilberto Lopes
- Abstract
Loading... -
+
P2.03-007 - Loxoprofen Prevents EGFR-TKI-Related Skin Rash in Non-Small Cell Lung Cancer Patients: A Single-Center Retrospective Study
09:30 - 09:30 | Presenter: Yohei Iimura | Author(s): H. Shimomura, K. Imanaka, Gaku Yamaguchi, N. Kawasaki, C. Konaka
- Abstract
Loading... -
+
P2.03-008 - Phase I/II Study of Intermitted Erlotinib in Combination with Docetaxel in Patients with Recurrent NSCLC with Wild-Type EGFR: WJOG 4708L
09:30 - 09:30 | Presenter: Tatsuo Kimura | Author(s): Tomoya Kawaguchi, S. Kudoh, Y. Chiba, H. Yoshioka, K. Watanabe, T. Kijima, Y. Kogure, T. Oguri, Naruo Yoshimura, T. Niwa, T. Kasai, Hidetoshi Hayashi, A. Ono, H. Tanaka, S. Yano, S. Nakamura, Nobuyuki Yamamoto, Yoichi Nakanishi, Kazuhiko Nakagawa
- Abstract
Loading... -
+
P2.03-009 - Clarification of Mechanisms of Acquired Resistance for Afatinib Using Plasma Samples
09:30 - 09:30 | Presenter: Tomomi Nakamura | Author(s): C. Nakashima, Kazutoshi Komiya, S. Kimura, Naoko Aragane
- Abstract
Loading... -
+
P2.03-010 - Updated Survival Outcomes of NEJ005/TCOG0902, a Randomized PII of Gefitinib and Chemotherapy in EGFR-Mutant NSCLC
09:30 - 09:30 | Presenter: Tatsuro Fukuhara | Author(s): S. Oizumi, S. Sugawara, K. Minato, T. Harada, A. Inoue, Y. Fujita, Satoshi Watanabe, K. Ito, Akihiko Gemma, Y. Demura, M. Harada, H. Isobe, I. Kinoshita, S. Morita, Kunihiko Kobayashi, K. Hagiwara, M. Kurihara, T. Nukiwa
- Abstract
Loading... -
+
P2.03-011 - Correlation and Problems of Re-Biopsy and Liquid Biopsy for Detecting T790M Mutation
09:30 - 09:30 | Presenter: Kazutoshi Komiya | Author(s): Tomomi Nakamura, M. Hayase, H. Hirakawa, S. Ogusu, Tomonori Abe, C. Nakashima, K. Takahashi, Y. Takeda, S. Kimura, N. Sueoka-Aragane
- Abstract
Loading... -
+
P2.03-012 - Characterization of the Efficacies of Osimertinib and Nazartinib against Cells Expressing Epidermal Growth Factor Receptor Mutations
09:30 - 09:30 | Presenter: Keita Masuzawa | Author(s): H. Yasuda, J. Hamamoto, I. Kawada, K. Naoki, K. Soejima, T. Betsuyaku
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.03-014 - A Phase I Study of Afatinib for Patients Aged 75 or Older with Advanced NSCLC Harboring EGFR Mutations
09:30 - 09:30 | Presenter: Hisashi Tanaka | Author(s): K. Baba, Y. Hasegawa, K. Taima, Y. Tanaka, M. Itoga, Y. Ishioka, T. Morimoto, H. Nakagawa, S. Takanashi, S. Tasaka
- Abstract
Loading... -
+
P2.03-015 - Efficacy of EGFR-TKIs for EGFR Mutatnt NSCLC Patients with Central Nervous System Metastases: A Retrospective Analysis
09:30 - 09:30 | Presenter: Kenichi Koyama | Author(s): Y. Saida, T. Abe, M. Satokata, Y. Mishina, K. Sato, Satoshi Shoji, T. Tanaka, K. Nozaki, K. Ichikawa, T. Miyabayashi, T. Ota, F. Fujimori, R. Ito, R. Kondo, T. Hiura, M. Okajima, S. Miura, Satoshi Watanabe, N. Matsumoto, H. Tanaka, T. Kikuchi
- Abstract
Loading... -
+
P2.03-016 - Clinical Utility of Liquid Biopsy for Detecting EGFR T790M Mutation Is Very Limited
09:30 - 09:30 | Presenter: Tomohiro Sakamoto | Author(s): Kohei Yamane, N. Tanaka, M. Yanai, H. Izumi, K. Yamaguchi, K. Takeda, H. Makino, T. Igishi, A. Yamasaki, E. Simizu
- Abstract
Loading... -
+
P2.03-017 - Clinical Features and Treatment with Afatinib in Patients with Squamous Cell Lung Cancer with Sensitive EGFR Mutations
09:30 - 09:30 | Presenter: Yuri Taniguchi | Author(s): A. Saihara, Y. Matsumoto, R. Furukawa, S. Ohara, A. Sato, M. Hojou, K. Usui
- Abstract
Loading... -
+
P2.03-018 - Diagnostic Yield of Fine-Needle Aspiration and Core-Needle Biopsy in Assessment of EGFR and ALK Mutation Status in Non–Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Junghoon Kim | Author(s): J. Kim
- Abstract
Loading... -
+
P2.03-019 - Sizing Capillary Electrophoresis with PCR to Detect Various EGFR Exon 19 Deletions in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Eiji Nakajima | Author(s): M. Sugita, K. Furukawa, H. Takahashi, Y. Kawaguchi, Tatsuo Ohira, Norihiko Ikeda, Fred R. Hirsch, W.A. Franklin
- Abstract
Loading... -
+
P2.03-020 - Pemetrexed Continuation Maintenance versus Conventional Platinum-based Doublet Chemotherapy in EGFR-negative Lung Adenocarcinoma: Retrospective Analysis
09:30 - 09:30 | Presenter: Seung Hyeun Lee | Author(s): I.K. Hwang, S.S. Paik, M.J. Park
- Abstract
Loading... -
+
P2.03-021 - A Phase I Study Evaluating the Combination of Afatinib, Carboplatin and Pemetrexed after Failure of 1St Generation EGFR-TKIs
09:30 - 09:30 | Presenter: Ou Yamaguchi | Author(s): Satoshi Watanabe, A. Masumoto, Y. Maeno, Y. Kawashima, O. Ishimoto, S. Sugawara, H. Yoshizawa, Kunihiko Kobayashi, T. Nukiwa
- Abstract
Loading... -
+
P2.03-022 - Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Jin-Hyoung Kang | Author(s): S. Hong, H.J. Ahn, K..H. Kim, S.S. Lee, Y.G. Lee, Y.J. Yuh, P. I Cheon, Y.S. Chae, T.W. Jang
- Abstract
Loading... -
+
P2.03-023 - Characteristics of NSCLC Patients Treated in First Line Treatment with Tyrosine Kinase Inhibitors (TKI) - Real Data from the Czech Republic
09:30 - 09:30 | Presenter: Jana Skrickova | Author(s): R. Chloupkova, Z. Bortlicek, M. Pesek, V. Kolek, K. Hejduk, L. Koubkova, M. Cernovska, J. Krejci, M. Zemanová, L. Havel, J. Roubec, M. Hrnciarik, F. Salajka, H. Coupkova, M. Satankova, A. Benejova, I. Grygarkova, P. Opalka, D. Sixtova
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.03-025 - Prevalence of EGFR T790M Mutation in NSCLC Patients after Afatinib Failure, and Subsequent Response to Osimertinib
09:30 - 09:30 | Presenter: Maximilian Johannes Hochmair | Author(s): S. Schwab, O. Burghuber, R. Koger, U. Setinek, A. Cseh, R. Fritz, A. Buder, Martin Filipits
- Abstract
Loading... -
+
P2.03-026 - Managing EGFR T790M Mutation in Advanced Non-Small Cell Lung Cancers in THAILAND
09:30 - 09:30 | Presenter: Thongbliew - Prempree
- Abstract
Loading... -
+
P2.03-027 - Comparative Longitudinal Toxicity Analysis of EGFR Mutated NSCLC Treated with Either Pemetrexed Carboplatin or Gefitinib
09:30 - 09:30 | Presenter: Mansi Sharma | Author(s): Vijay Patil, A. Joshi, V. Noronha, A. Bhattarjee, S. Goud, S.B. More, A. Ramaswamy, A.P. Karpe, N. Pande, A. Chandrasekharan, Alok Goel, Vikas Talreja, K. Prabhash
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.03-029 - A Case of a Patient Harboring an EGFR Insertion of Exon 20 and Long Lasting Clinical Response to Afatinib
09:30 - 09:30 | Presenter: Ana Caroline Zimmer Gelatti | Author(s): V. Lorandi, G.D.S. Macedo, V.K. Gonçalves, R. Piccoli, S.D. Stefani
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.03-031 - Efficacy of Gefitinib and Radiotherapy Combination in Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Elisna Syahruddin | Author(s): A.L. Huswatun, A. Prabowo, Sita Andarini, J. Zaini, A. Hudoyo, A. Jusuf
- Abstract
Loading... -
+
P2.03-032 - Efficacy and Safety of Osimertinib as Third-Line or Later Therapy for T790M-Positive Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Hiroyuki Shimada | Author(s): S. Endo, Y. Sasahara, T. Shinmura, T. Ozawa, H. Majima, T. Hara, Reina Imase, S. Yamauchi, Y. Sakakibara, A. Kobayashi, K. Yamazaki, Y. Jin, K. Yamanaka, O. Matsubara
- Abstract
Loading... -
+
P2.03-033 - Propensity Score-Adjusted Survival Analysis of Non-Small Cell Lung Cancer Patients with Acquired Resistance to EGFR-TKI
09:30 - 09:30 | Presenter: Sho Watanabe | Author(s): Y. Takeda, H. Kawamoto, S. Fujimoto, G. Naka, H. Sugiyama
- Abstract
Loading... -
+
P2.03-034 - EGFR Exon 19 Deletion Is Associated with Favorable Overall Survival After First-Line Icotinib Therapy in Advanced NSCLC Patients
09:30 - 09:30 | Presenter: Xiaochun Zhang | Author(s): C. Zhang, H. Hou, X. Cheng, D. Gong, H. Liu, H. Yu, W. Zhu, J. Zhu, K. Liu, H. Lv, N. Zhou, J. Cong, D. Liu, L. Yang, M. Jiang, Y. Zhang, L. Chen, Y. Zhu
- Abstract
Loading... -
+
P2.03-035 - Osimertinib in Relapsed EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases: Results from the TREM-Study
09:30 - 09:30 | Presenter: Inger Johanne Zwicky Eide | Author(s): Å. Helland, S. Borrisova, Simon Ekman, S. Cicenas, J. Koivunen, B.H. Grønberg, O.T. Brustugun
- Abstract
Loading... -
+
P2.03-036 - Comparing the Efficacy/Toxicity of Osimertinib and First Line EGFR-TKI by Individual Patient Analysis
09:30 - 09:30 | Presenter: Shoko Narita | Author(s): Yasushi Goto, J. Sato, R. Morita, S. Murakami, Shintaro Kanda, Hidehito Horinouchi, Y. Fujiwara, N. Yamamoto, Yuichiro Ohe
- Abstract
Loading... -
+
P2.03-037 - Osimertinib in Relapsed EGFR-Mutated, T790M-Negative Non-Small Cell Lung Cancer (NSCLC) Patients: Results from the TREM-Study
09:30 - 09:30 | Presenter: Inger Johanne Zwicky Eide | Author(s): Å. Helland, S. Borrisova, Simon Ekman, S. Cicenas, J. Koivunen, B.H. Grønberg, O.T. Brustugun
- Abstract
Loading... -
+
P2.03-038 - Early Serum Tumor Markers After 14 Days of Tyrosine Kinase Inhibitor Target Therapy Predicts Outcomes in Patients with Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Kuo-Yang Huang | Author(s): H. Chen
- Abstract
Loading... -
+
P2.03-039 - Compassionate Use of Osimertinib: Argentine Experience
09:30 - 09:30 | Presenter: Jose Nicolas Minatta | Author(s): L. Lupinacci, G. Recondo, S. Sena, G. Boggio, A. Muggeri, C. Rosenbrock, F. Cayol, M. Angel, M. Muñoz, S. Berutti, N. Castagneris, D. Gomez Bradley, J.M. Lastiri
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.03-041 - The Concentration of Avitinib in Cerebrospinal Fluid and Its Efficacy and Safety in NSCLC Patients with T790M Mutation
09:30 - 09:30 | Presenter: Hanping Wang | Author(s): L. Zhang, X. Zheng, X. Si, Xiaoxia Cui, M. Wang
- Abstract
Loading... -
+
P2.03-042 - EGFR Mutation and Erlotinib Efficacy in Turkish Oncoregistry
09:30 - 09:30 | Presenter: Mahmut Gumus | Author(s): M. Ozkan, U. Yilmaz, S.B. Tekin, C. Demir, A. Erdogan, Faysal Dane
- Abstract
Loading... -
+
P2.03-043 - A Phase 1b Study of Erlotinib and Momelotinib for TKI-Naïve EGFR-Mutated Metastatic Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Sukhmani Kaur Padda | Author(s): Karen L Reckamp, M. Koczywas, Joel W. Neal, J. Kawashima, S. Kong, Y. Xin, D. Huang, Heather A Wakelee
- Abstract
Loading... -
+
P2.03-044 - OSCILLATE - Phase 2 Trial of Alternating Osimertinib with Gefitinib in Patients with EGFR-T790M Mutation Positive Advanced NSCLC
09:30 - 09:30 | Presenter: Ben J Solomon | Author(s): P. Kok, A. Livingstone, S. Yip, C. Brown, S. Dawson, S. Wong, Nick Pavlakis, M. Stockler
- Abstract
Loading... -
+
P2.03-045 - Updated Results of Phase II, Liquid Biopsy Study in EGFR Mutated NSCLC Patients Treated with Afatinib (WJOG 8114LTR)
09:30 - 09:30 | Presenter: Hidetoshi Hayashi | Author(s): H. Akamatsu, Y. Koh, S. Morita, Daichi Fujimoto, Isamu Okamoto, A. Bessho, K. Azuma, Kazuhiko Nakagawa, Nobuyuki Yamamoto
- Abstract
Loading... -
+
P2.03-046 - Lymhocyte-To-Monocyte Ratio and Mean Platelet Volume as Prognostic Factor in EGFR Mutant NSCLC Treated with EGFR TKI
09:30 - 09:30 | Presenter: Kousuke Watanabe | Author(s): Y. Amano, H. Kage, Yasushi Goto, D. Takai, T. Nagase
- Abstract
Loading... -
+
P2.03-047 - The Main Treatment Failure Pattern for Completely Resected Stage II–IIIA (N1–N2) EGFR-Mutation Positive Lung Cancer
09:30 - 09:30 | Presenter: Songtao Xu | Author(s): W. Zhong, Y. Zhang, W. Mao, L. Wu, Y. Shen, Y. Liu, C. Chen, Ying Cheng, L. Xu, J. Wang, K. Fei, X. Li, J. Li, C. Huang, Z. Liu, S. Xu, K. Chen, S. Xu, L. Liu, P. Yu, B. Wang, H. Ma, H. Yan, X. Yang, Yi-Long Wu, Q. Wang
- Abstract
Loading... -
+
P2.03-048 - Mixed Response of Non-Small Cell Lung Cancer Harboring the EGFR T790M Mutation to Osimertinib
09:30 - 09:30 | Presenter: Yuki Shinno | Author(s): Yasushi Goto, J. Sato, R. Morita, Y. Matsumoto, S. Murakami, Shintaro Kanda, Hidehito Horinouchi, Y. Fujiwara, N. Yamamoto, Yuichiro Ohe
- Abstract
Loading... -
+
P2.03-049 - Pulmonary Adenoid Cystic Carcinoma with EGFR Activating Mutation and Responds Well with Tyrosine Kinase Inhibitor
09:30 - 09:30 | Presenter: Jamal Zaini | Author(s): Sita Andarini, Elisna Syahruddin, A. Hudoyo
- Abstract
Loading... -
+
P2.03-050 - The Efficacy of EGFR Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer Harboring G719X Mutation
09:30 - 09:30 | Presenter: Hanping Wang | Author(s): L. Zhang, T. Lu, X. Zhang, Xiaoyan Si, M. Wang
- Abstract
Loading... -
+
P2.03-051 - The Impact of EGFR Mutations. Treatment with ITKs in Non Small Cell Lung Cancer Patients
09:30 - 09:30 | Presenter: Teresa García Manrique | Author(s): O. Saavedra, N. Palazón Carrión, C. Pérez Gago, J. Calvete, R. Carrillo, F.J. Valdivia García, D. Vicente Baz
- Abstract
Loading... -
+
P2.03-052 - Local Ablative Therapy for Oligoprogressive, EGFR-Mutant, Non-Small Cell Lung Cancer (NSCLC) After Treatment with Osimertinib
09:30 - 09:30 | Presenter: Udayan Guha | Author(s): C. Kim, N. Roper, C.D. Hoang, M. Connolly, C.M. Cultraro, E. Szabo, M. Waris, E. Padiernos, A.H. Kesarwala, S. Gao, S.M. Steinberg, D.T.W. Wong, J. Khan, A. Rajan
- Abstract
Loading... -
+
P2.03-053 - A Five-Year Audit of EGFR and ALK Testing at a Tertiary Care Centre in North India: More Sensitive Methods Do Make a Difference!
09:30 - 09:30 | Presenter: Valliappan Muthu | Author(s): A. Bal, N. Gupta, Kuruswamy Thurai Prasad, Digambar Behera, Navneet Singh
- Abstract
Loading... -
+
P2.03-054 - EGFR Mutation with Acquired C-MET Positive Reveals Potential Immunotherapeutic Vulnerabilities
09:30 - 09:30 | Presenter: Shan Su | Author(s): Z.Y. Dong, Jin -Ji Yang, X. Zhang, Z. Xie, J. Su, Z. Chen, Yi-Long Wu
- Abstract
Loading... -
+
P2.03-055 - Comparison of Afatinib Versus Erlotinib for Advanced Non-Small-Cell Lung Cancer Patients with Resistance to EGFR-TKI
09:30 - 09:30 | Presenter: Yuichi Sakamori | Author(s): Yuto Yasuda, Tomoko Funazo, T. Nomizo, T. Tsuji, Hironori Yoshida, H. Nagai, H. Ozasa, T. Hirai, Y.H. Kim
- Abstract
Loading... -
+
P2.03-056 - Primary Double EGFR Mutations T790M and Mutation in Exon 19 or 21 in Slovakian NSCLC Patients - Updated Survival Data
09:30 - 09:30 | Presenter: Peter Berzinec | Author(s): P. Kasan, R. Godal, L. Plank, L. Copakova, A. Alemayehu, G. Chowaniecova, A. Farkasova, P. Hlavcak, M. Kucma, L. Rotikova, M. Slavikova, P. Vasovcak
- Abstract
Loading... -
+
P2.03-057 - Effectiveness of Icotinib on Uncommon EGFR Exon 20 Insert Mutations: A763_Y 764insFQEA in Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, Rongrong Chen, Y. Guan, X. Yi, Gang Chen, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P2.03-058 - Tiger-3: A Phase 3 Randomized Study of Rociletinib Vs Chemotherapy in EGFR-mutated Non-small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: James Chih-Hsin Yang | Author(s): Karen L Reckamp, Young-Chul Kim, Silvia Novello, Egbert F Smit, J. Lee, W. Su, W.L. Akerley, C. Blakely, Lyudmila A Bazhenova, R. Chiari, T. Hsia, T. Golsorkhi, D. Despain, D. Shih, L. Rolfe, Sanjay Popat, Heather A Wakelee
- Abstract
Loading... -
+
P2.03-058a - T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive NSCLC
09:30 - 09:30 | Presenter: Takeshi Yoshida | Author(s): S. Watanabe, H. Kawakami, N. Takegawa, Junko Tanizaki, Hidetoshi Hayashi, M. Takeda, Kimio Yonesaka, J. Tsurutani, Kazuhiko Nakagawa
- Abstract
No abstract available for this presentation
-
+
P2.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
-
+
P2.04-001 - BALTIC: A Phase 2, Open-Label Study of Novel Combinations of Immunotherapies or DDR Inhibitors in Platinum-Refractory ED-SCLC
09:30 - 09:30 | Presenter: Ihor Vynnychenko | Author(s): H. Jiang, Y. Huang, P.A. Dennis, J. Von Pawel
- Abstract
Loading... -
+
P2.04-002 - CASPIAN: Phase 3 Study of First-Line Durvalumab ± Tremelimumab + Platinum-Based Chemotherapy vs Chemotherapy Alone in ED-SCLC
09:30 - 09:30 | Presenter: Luis Paz-Ares | Author(s): H. Jiang, Y. Huang, P.A. Dennis
- Abstract
Loading... -
+
P2.04-003 - Phase II Trial of X-396 (Ensartinib) for Chinese Patients with ALK (+) Non–Small-Cell Lung Cancer Who Progressed on Crizotinib
09:30 - 09:30 | Presenter: Li Zhang | Author(s): Junling Li, W. Zhong, Y. Hu, X. Liu, Z. Wang, Y. Zhao, J. Feng, J. Zhou, Y. Zhang, Yun Fan, G. Wu, F. Tan, L. Ding
- Abstract
Loading... -
+
P2.04-004 - IMpower010: A Phase III Study of Atezolizumab vs Best Supportive Care Following Adjuvant Chemotherapy in Completely Resected NSCLC
09:30 - 09:30 | Presenter: Enriqueta Felip | Author(s): Heather A Wakelee, Eric Vallieres, Caicun Zhou, Y. Zuo, F. Xia, A. Sandler, Nasser Altorki
- Abstract
Loading... -
+
P2.04-005 - GEOMETRY Mono-1: Phase II, Multicenter Study of MET Inhibitor Capmatinib (INC280) in EGFR Wt, MET-Dysregulated Advanced NSCLC
09:30 - 09:30 | Presenter: Jürgen Wolf | Author(s): Ji-Youn Han, Makoto Nishio, P. Souquet, Luis Paz-Ares, F. De Marinis, Takashi Seto, M. De Jonge, T.M. Kim, Johan F. Vansteenkiste, Daniel SW Tan, Edward Brian Garon, H.J. Groen, Maximilian Johannes Hochmair, Enriqueta Felip, Noemi Reguart, M. Thomas, T.R. Overbeck, K. Ohashi, M. Giovannini, R. Yura, A. Joshi, M. Akimov, R. Heist
- Abstract
Loading... -
+
P2.04-006 - ADAURA: PhIII, Double-Blind, Randomized Study of Osimertinib vs Placebo in EGFR Mutation-Positive NSCLC Post-Tumor Resection
09:30 - 09:30 | Presenter: Roy S. Herbst | Author(s): Yi-Long Wu, H. Mann, Y. Rukazenkov, M. Marotti, M. Tsuboi
- Abstract
Loading... -
+
P2.04-007 - KEYNOTE-604: Phase 3 Randomized, Double-Blind Trial of Pembrolizumab/Placebo plus Etoposide/Platinum for Extensive Stage-SCLC
09:30 - 09:30 | Presenter: Charles M Rudin | Author(s): L. Shen, M.C. Pietanza
- Abstract
Loading... -
+
P2.04-008 - ATLANTIS: Phase III Study of PM01183 with Doxorubicin vs. CAV or Topotecan in Small-Cell Lung Cancer After Platinum Therapy
09:30 - 09:30 | Presenter: Jose Antonio Lopez-Vilariño | Author(s): A. Farago, Luis Paz-Ares, A. Fülop, A. Chiappori, K. Syrigos, C. Kahatt, G. Kos, A. Soto-Matos
- Abstract
Loading... -
+
P2.04-009 - Randomized, Single-Blind Phase 1 Study of Pharmacokinetic Equivalence of ABP 215 Relative to Bevacizumab in Japanese Subjects
09:30 - 09:30 | Presenter: Valdimir Hanes | Author(s): V. Chow, J. Pan, R. Markus
- Abstract
Loading... -
+
P2.04-010 - Afatinib in Combination with Pembrolizumab in Patients with Stage IIIB/IV Squamous Cell Carcinoma (SCC) of the Lung
09:30 - 09:30 | Presenter: Jonathan W Riess | Author(s): Jaafar Bennouna, Luis Paz-Ares, M.J. Chisamore, C. Lybeck Lind, B. Sadrolhefazi, B. Levy
- Abstract
Loading... -
+
P2.04-011 - The Using of LungCare Electromagnetic Navigated Bronchoscopy System in Lung Lesions, a New Project in China
09:30 - 09:30 | Presenter: Baohui Han | Author(s): S. Jiayuan, X. Zheng
- Abstract
Loading... -
+
P2.04-012 - First-Line Ensartinib (X396) versus Crizotinib in Advanced ALK-Rearranged NSCLC (eXalt3): A Randomized, Open-Label, Phase 3 Study
09:30 - 09:30 | Presenter: Yi-Long Wu | Author(s): Tony SK Mok, Martin Reck, Heather A Wakelee, C. Liang, F. Tan, K. Harrow, V. Oertel, G. Dukart, L. Ding, L. Horn
- Abstract
Loading... -
+
P2.04-013 - ElevatION:NSCLC-101 – A Phase 1b Study of PDR001 Combined with Chemotherapy in PD-L1 Unselected, Metastatic NSCLC Patients
09:30 - 09:30 | Presenter: Enriqueta Felip | Author(s): Johan F. Vansteenkiste, Frances A Shepherd, Luis Paz-Ares, Fabrice Barlesi, S. Burgers, C. Cai, F. Kiertsman, J. Scott, T. McCulloch, Y.Y. Lau, D. Morgensztern
- Abstract
Loading... -
+
P2.04-014 - Computing the Impact of Immunotherapy on NSCLC Landscape: The Advanced Non-Small Cell Lung Cancer Holistic Registry (ANCHoR)
09:30 - 09:30 | Presenter: George R. Simon | Author(s): S. Chandwani, V.B. Vaghani, M. Hirschmann, L. Lacerda Landry, E. Roarty, Jianjun Zhang, Qiuling Shi, W. Rinsurnogkawong, J. Lewis, L.A. Williams, C.S. Cleeland, T. Burke, Jack Lee, J. Roth, Stephen Swisher, John V Heymach
- Abstract
Loading...
-
+
P2.05 - Early Stage NSCLC
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Early Stage NSCLC
-
+
P2.05-001 - Does CGA Impact QoL and Overall Survival in NSCLC Patients Treated with SBRT - Results of a Randomized Pilot Study
09:30 - 09:30 | Presenter: Stefan Starup Jeppesen | Author(s): Olfred Hansen, L. Matzen
- Abstract
Loading... -
+
P2.05-002 - A Pilot Study on the Safety and the Efficacy of Dose Escalation in Stereotactic Body Radiotherapy for Peripheral Lung Tumor
09:30 - 09:30 | Presenter: Takamasa Mitsuyoshi | Author(s): Yukinori Matsuo, Takashi Shintani, Y. Iizuka, N. Ueki, T. Mizowaki
- Abstract
Loading... -
+
P2.05-003 - Stage by Stage Comparison of Radiotherapy versus Surgery in NSCLC: The Influence of Prognostic Factors on Survival Outcome
09:30 - 09:30 | Presenter: Sara Moore | Author(s): Bonnie Leung, J. Wu, C. Ho
- Abstract
Loading... -
+
P2.05-004 - Radiotherapy Patterns of Care for Stage I and II Non-small-cell Lung Cancer in Sydney, Australia
09:30 - 09:30 | Presenter: Andrew Duy Duc Nguyen | Author(s): J. Shafiq, W. Wong, N. Beydoun, Sharanya Mohan, S.K. Vinod
- Abstract
Loading... -
+
P2.05-005 - Proton Beam Therapy for Early Stage Lung Cancer: A Multi-Institutional Retrospective Study in Japan
09:30 - 09:30 | Presenter: Kayoko Ohnishi | Author(s): H. Harada, N. Nakamura, S. Tokumaru, H. Wada, T. Arimura, H. Iwata, Y. Sato, Y. Sekino, H. Tamamura, J. Mizoe, T. Ogino, H. Ishikawa, Y. Kikuchi, T. Okimoto, S. Murayama, T. Akimoto, H. Sakurai
- Abstract
Loading... -
+
P2.05-006 - Credentialing of Radiotherapy Centres in Australasia for a Phase III Clinical Trial on SABR (TROG 09.02 CHISEL)
09:30 - 09:30 | Presenter: Nicholas Hardcastle | Author(s): T. Kron, B. Chesson, M. Burns, M. Crain, David L Ball
- Abstract
Loading... -
+
P2.05-007 - Sterotactic-Body-Radiotherapy for Early-Lung Cancer: Is FDG-PET/TC a Predictor of Outcome?
09:30 - 09:30 | Presenter: Margarita Majem | Author(s): N. Farré, M.D.V. Camacho, A. Fernández, J. Balart, G. Sancho, K. Majercakova, E. Acosta, P. Carrasco, A. Giménez, E. Martínez, J.C. Trujillo, A. Torrego, V. Pajares, J. Craven-Bartle
- Abstract
Loading... -
+
P2.05-008 - Stereotactic Body Radiotherapy (SBRT) for Early Stage I Lung Cancer: A Review from an Oncology Center in Hong Kong
09:30 - 09:30 | Presenter: Lim Mei Ying | Author(s): M. Tong, C. Chi Kin
- Abstract
Loading... -
+
P2.05-009 - Outcome of Stereotactic Body Radiotherapy for Clinical Stage I Non Small Cell Lung Cancer and CT Findings: Comparison with Surgical Resection
09:30 - 09:30 | Presenter: Yuho Maki | Author(s): T. Ueno, R. Sugimoto, Daijiro Harada, K. Uwatsu, T. Kozuki, A. Nishikawa, N. Nogami, M. Kataoka, Motohiro Yamashita
- Abstract
Loading... -
+
P2.05-010 - Changes between Pre- and Post-Operative AICS (Lung) in NSCLC Patients: Predictability of High-Risk Cases with Recurrence
09:30 - 09:30 | Presenter: Masahiko Higashiyama | Author(s): Takashi Anayama, J. Okami, T. Tokunaga, H. Yamamoto, S. Kikuchi, A. Ikeda, K. Orihashi, F. Imamura
- Abstract
Loading... -
+
P2.05-011 - Segmentectomy versus Wedge Resection in Patients with Clinical Stage I Non-Small Cell Lung Cancer Who Were Unfit for Lobectomy
09:30 - 09:30 | Presenter: Yasuhiro Tsutani | Author(s): R. Hirohata, T. Tasaki, H. Hanaki, Y. Miyata, Morihito Okada
- Abstract
Loading... -
+
P2.05-012 - Prognostic Factors for Surgically Resected Non-Small Cell Lung Cancer with Cavity Formation
09:30 - 09:30 | Presenter: Shunsuke Shigefuku | Author(s): Y. Kudo, D. Yunaiyama, J. Matsubayashi, J. Park, T. Nagao, Yoshihisa Shimada, M. Hagiwara, H. Saji, T. Okano, Masatoshi Kakihana, Naohiro Kajiwara, Tatsuo Ohira, Norihiko Ikeda
- Abstract
Loading... -
+
P2.05-013 - The Result of Preoperative Lipiodol Markings for 121 Small Pulmonary Nodules in 115 Patients
09:30 - 09:30 | Presenter: Hirofumi Suzuki | Author(s): Motohiro Nishimura, Junichi Shimada
- Abstract
Loading... -
+
P2.05-014 - Factors Associated with Recovery Time to Predicted FEV1 in Non-Small-Cell Lung Cancer Patients after Lobectomy
09:30 - 09:30 | Presenter: Shin Ah Young | Author(s): H.W. Kim, J.H. Ha, J.S. Kim, J.H. Ahn
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.05-016 - Clinical Importance and Application of New T Descriptors in the 8th TNM Classification for Pathological T0-1 Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Masayuki Nakao | Author(s): H. Ninomiya, Junji Ichinose, Mingyon Mun, K. Nakagawa, Yuichi Ishikawa, S. Okumura
- Abstract
Loading... -
+
P2.05-017 - Prognostic Impact of the Clinical T Descriptor in the Eighth Edition of the TNM Staging System of Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Tatsuro Okamoto | Author(s): M. Miyawaki, Gouji Toyokawa, M. Abe, Y. Takumi, T. Hashimoto, R. Kobayashi, Atsushi Osoegawa, T. Tagawa, H. Takeuchi, Y. Maehara, K. Sugio
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.05-019 - Overall Survival (OS) of Pathological T1N0 Non-Small Cell Lung Cancer (NSCLC) After Resection.
09:30 - 09:30 | Presenter: Etienne Bourdages-Pageau | Author(s): Arthur Vieira, C. Labbé, P.A. Ugalde Figueroa
- Abstract
Loading... -
+
P2.05-020 - Prognostic Factors in Patients with Completely Resected Subsolid Node-Negative Lung Adenocarcinoma of 3cm or Smaller
09:30 - 09:30 | Presenter: Jung-Jyh Hung | Author(s): W. Hsu
- Abstract
Loading... -
+
P2.05-021 - Occult Nodal Metastasis Following Lobectomy for Clinical Stage I Lung Adenocarcinoma: Implications for Sublobar Resection
09:30 - 09:30 | Presenter: Yusuke Takahashi | Author(s): Takashi Eguchi, Kay See Tan, S. Lu, J. Dozier, William D Travis, D. Jones, Prasad S. Adusumilli
- Abstract
Loading...
-
+
P2.06 - Epidemiology/Primary Prevention/Tobacco Control and Cessation
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Epidemiology/Primary Prevention/Tobacco Control and Cessation
-
+
P2.06-001 - Circulating Cotinine Concentrations, Self-Reported Smoking, and Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3)
09:30 - 09:30 | Presenter: Tricia L. Larose | Author(s): F. Guida, P. Brennan, M. Johansson
- Abstract
Loading... -
+
P2.06-002 - Tobacco Use and Prevalence of Head and Neck Cancers among Malayali Tribes, Yelagiri Hills, Tamil Nadu, India
09:30 - 09:30 | Presenter: Delfin Lovelina Francis
- Abstract
Loading... -
+
P2.06-003 - Retrospective Study of Cerebral Thromboembolism Occurring before and after Detection of Lung Cancer (Trousseau Syndrome)
09:30 - 09:30 | Presenter: Kinnosuke Matsumoto | Author(s): Y. Tanio, T. Yanase, K. Kuno, Yuichi Mitsui, Y. Shirai, M. Suzuki, J. Uchida, K. Ueno, Y. Funakoshi, H. Takabatake, S. Shimamoto, N. Tamaki, H. Fushimi, K. Shimazu
- Abstract
Loading... -
+
P2.06-004 - Role of Polymorphic Variants of BER and DSBR Pathway Genes in Modulating Lung Cancer Susceptibility and Prognosis of North Indian Population
09:30 - 09:30 | Presenter: Amrita Singh | Author(s): S. Sharma, Navneet Singh, D. Behera
- Abstract
Loading... -
+
P2.06-005 - An Exploration of Attitudes and Barriers to Uptake of Lung Cancer Screening in at Risk Adults in the United Kingdom
09:30 - 09:30 | Presenter: David Raymond Baldwin | Author(s): E.L. O'Dowd, M. Bains, R.B. Hubbard, T. McKeever, J. Solomon
- Abstract
Loading... -
+
P2.06-006 - Screening Values of CEA and Cyfra 21-1 for Lung Cancer in Combination with Low Dose CT (LDCT) in High-Risk Populations
09:30 - 09:30 | Presenter: Natthaya Triphuridet | Author(s): S. Vidhyarkorn, N. Chungklay, C. Auewarakul, J. Patumanond
- Abstract
Loading... -
+
P2.06-007 - Demographic Characteristics of Lung Cancer and Association with Wood Smoke in Mexican Population
09:30 - 09:30 | Presenter: Jeronimo Rafael Rodriguez-Cid | Author(s): V. Imaz-Olguín, D. Bonilla-Molina, J.A. Alatorre Alexander, L. Martínez-Barreda, G. Martos-Ramírez, D. Gree-Renner, R. Gerson-Cwilich
- Abstract
Loading... -
+
P2.06-008 - Diagnosis of Incidental Disease in Medicaid Recipients During Lung Cancer Screening
09:30 - 09:30 | Presenter: Marisa Bittoni | Author(s): D. Tumin, G. Venious, F. Duncan, David P Carbone, E. Crouser, E. Jackson
- Abstract
Loading... -
+
P2.06-009 - Trace Elements Affect Lung Cancer Subtypes
09:30 - 09:30 | Presenter: Ryosuke Chiba | Author(s): N. Morikawa, K. Sera, S. Moriguchi, H. Saito, W. Shigeeda, H. Deguchi, M. Tomoyasu, T. Tanita, K. Ishida, T. Sugai, K. Yamauchi, M. Maemondo
- Abstract
Loading... -
+
P2.06-010 - Association of Vitamin D Receptor BsmI Polymorphism with Lung Cancer Risk: Evidence from a Meta-Analysis
09:30 - 09:30 | Presenter: Minhua Shi | Author(s): A. Zhong
- Abstract
Loading... -
+
P2.06-011 - Assessing and Addressing Knowledge Gaps to Improve Lung Cancer Screening Rates
09:30 - 09:30 | Presenter: Lawrence Eric Feldman | Author(s): G. Westphal, M. Pasquinelli, T. Schmidt
- Abstract
Loading...
-
+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P2.07-001 - Clinicopathological Characteristics of NSCLC Patients with Nivolumab-Induced Pneumonitis
09:30 - 09:30 | Presenter: Nobuyuki Koyama
- Abstract
Loading... -
+
P2.07-002 - Drug-Related Pneumonitis in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Commercial PD-1 Inhibitors
09:30 - 09:30 | Presenter: Mizuki Nishino | Author(s): A.E. Adeni, H. Hatabu, C.A. Lydon, T. Hida, F..S. Hodi, M.M. Awad
- Abstract
Loading... -
+
P2.07-003 - Nivolumab for Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Hironori Yoshida | Author(s): Y.H. Kim, H. Ozasa, H. Nagai, Yuichi Sakamori, T. Tsuji, T. Nomizo, Tomoko Funazo, Yuto Yasuda, T. Hirai
- Abstract
Loading... -
+
P2.07-004 - Immune-Related Adverse Events (irAEs) of Nivolumab Predicts Clinical Benefit in Advanced Lung Cancer Patients
09:30 - 09:30 | Presenter: Yukihiro Toi | Author(s): S. Sugawara, Y. Kawashima, T. Aiba, K. Tsurumi, K. Suzuki, H. Shimizu, J. Sugisaka, H. Ono, Y. Domeki, S. Kawana, R. Saito, K. Terayama, A. Nakamura, S. Yamanda, Y. Kimura, Y. Honda
- Abstract
Loading... -
+
P2.07-005 - Impact of Baseline Leptomeningeal and Brain Metastases on Immunotherapy Outcomes in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
09:30 - 09:30 | Presenter: Laura Mezquita | Author(s): C. Henon, E. Auclin, S. Ammari, C. Caramella, Cecile Le Pechoux, A. Botticella, David Planchard, A. Gazzah, R. Ferrara, J. Lahmar, G. Martinez-Bernal, J. Adam, J. Soria, Benjamin Besse
- Abstract
Loading... -
+
P2.07-006 - Irinotecan Augmented Anti-Tumor Activity of Anti-PD-L1 through Enhancing CD8 Proliferation Regardless of Its Hematotoxicity
09:30 - 09:30 | Presenter: Toshiki Iwai | Author(s): M. Sugimoto, D. Wakita, K. Yorozu, M. Kurasawa, K. Yamamoto
- Abstract
Loading... -
+
P2.07-007 - Retrospective Analysis of Antitumor Effects and Biomarkers of Nivolumab in NSCLC Patients with EGFR Mutations
09:30 - 09:30 | Presenter: Satoshi Watanabe | Author(s): H. Tanaka, K. Nozaki, M. Sato, M. Arita, Y. Mishina, Satoshi Shoji, K. Ichikawa, R. Kondo, T. Sakagami, T. Koya, T. Kikuchi
- Abstract
Loading... -
+
P2.07-008 - Does PD-L1 Expression of the Archive Surgical Specimen of Primary Tumor Predict the Sensitivity of Recurrence to Nivolumab in Patients with NSCLC?
09:30 - 09:30 | Presenter: Yuki Shiina | Author(s): H. Suzuki, Yuichi Sakairi, H. Tamura, H. Wada, T. Fujiwara, Takahiro Nakajima, M. Chiyo, M. Ota, S. Ota, Y. Nakatani, I. Yoshino
- Abstract
Loading... -
+
P2.07-009 - Monitoring Nivolumab Binding as a Method to Clarify the Residual Therapeutic Effects in Previously Treated Lung Cancer Patients
09:30 - 09:30 | Presenter: Akio Osa | Author(s): S. Koyama, T. Uenami, K. Fujimoto, Y. Naito, H. Hirata, T. Takimoto, I. Nagatomo, Y. Takeda, H. Kida, M. Mori, T. Kijima, A. Kumanogoh
- Abstract
Loading... -
+
P2.07-010 - Impact of Clinicopathological Features on the Efficacy of PD-1/PD-L1 Inhibitors in Patients with Previously Treated Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Tao Jiang | Author(s): M. Qiao, Caicun Zhou
- Abstract
Loading... -
+
P2.07-011 - Long Follow up from Phase I Study of Nivolumab and Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Shintaro Kanda | Author(s): Yuichiro Ohe, Y. Matsumoto, S. Murakami, Yasushi Goto, Hidehito Horinouchi, Y. Fujiwara, H. Nokihara, N. Yamamoto, T. Yamamoto, T. Tamura
- Abstract
Loading... -
+
P2.07-012 - Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Martin Früh | Author(s): S. Schmid, S. Diem, M. Krapf, Q. Li, L. Flatz, S. Leschka, L. Desbiolles, D. Klingbiel, W. Jochum
- Abstract
Loading... -
+
P2.07-013 - Efficacy and Safety of Nivolumab in Non-Small Cell Lung Cancer with Preexisting Interstitial Lung Disease
09:30 - 09:30 | Presenter: Osamu Kanai | Author(s): Y.H. Kim, Y. Demura, M. Kanai, K. Fujita, Hironori Yoshida, M. Akai, T. Mio, T. Hirai
- Abstract
Loading... -
+
P2.07-014 - Immune Checkpoint Inhibitors for Brain Metastases of Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Hironori Ashinuma | Author(s): M. Shingyoji, T. Iuchi, Y. Yoshida, T. Setoguchi, Y. Hasegawa, T. Sakaida
- Abstract
Loading... -
+
P2.07-015 - Reviving Chemotherapy Sensitivity after Anti-CCR4 mAb (Mogamulizumab) Treatment in Lung Cancer Patients
09:30 - 09:30 | Presenter: Koji Kurose | Author(s): Yoshihiro Ohue, M. Isobe, S. Suzuki, H. Wada, R. Ueda, E. Nakayama, M. Oka
- Abstract
Loading... -
+
P2.07-016 - Inmunotherapy: Which Is More Important, Choosing Patients Who Will Respond or Identifying Those Who Will Die Early?
09:30 - 09:30 | Presenter: Inmaculada Ramos García | Author(s): M. Berciano, M. Dominguez, J. Baena, A. Godoy, L. Pérez, L. Galvez, M. Robles, T. Redondo, C. Quero, M.I. Sáez, M. Trigo
- Abstract
Loading... -
+
P2.07-017 - Association between Thyroid Dysfunction and Progression-Free Survival in Patients with Non-Small Cell Lung Cancer Received Nivolumab
09:30 - 09:30 | Presenter: Tomoko Funazo | Author(s): H. Ozasa, T. Nomizo, Yuto Yasuda, T. Tsuji, Hironori Yoshida, Yuichi Sakamori, H. Nagai, T. Hirai, Y.H. Kim
- Abstract
Loading... -
+
P2.07-018 - Correlation of Clinical Response and XAGE1 Immunity in Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Yoshihiro Ohue | Author(s): K. Kurose, M. Isobe, Minoru Fukuda, E. Nakayama, M. Oka
- Abstract
Loading... -
+
P2.07-019 - Role of Anti-Angiogenesis on the Prognosis in Advanced Non-Small Cell Lung Cancer Who Are Treated with Immunotherapy
09:30 - 09:30 | Presenter: Takefumi Komiya | Author(s): C.H. Huang, P. Neupane, P. Chalise
- Abstract
Loading... -
+
P2.07-020 - Distinct Immune Status in Patients with Adenocarcinoma and Squamous Cell Carcinoma: Implication for Immunotherapy of NSCLC
09:30 - 09:30 | Presenter: Nada Hradilova | Author(s): Ond?ej Palata, L. Sadilova, D. Myšíková, H. Mrazkova, R. Lischke, R. Špíšek, I. Adkins
- Abstract
Loading... -
+
P2.07-021 - A Checkpoint Molecule B7-H3 as a Novel Immune Therapy Target for Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Kimio Yonesaka | Author(s): K. Kudoh, S. Takamura, H. Sakai, R. Kato, K. Haratani, T. Takahama, K. Tanaka, Hidetoshi Hayashi, H. Kaneda, M. Takeda, O. Maenishi, M. Yamato, M. Miyazawa, Kazuto Nishio, Kazuhiko Nakagawa
- Abstract
Loading... -
+
P2.07-022 - Inflammatory Cytokine Induction after Anti-PD-1 Ab Administration Relates to the Efficacy and Safety in Patients with Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Yuichi Ozawa | Author(s): Y. Amano, T. Koyauchi, T. Kakutani, Y. Sato, H. Hasegawa, T. Matsui, M. Tanahashi, H. Niwa, K. Yokomura, T. Suda
- Abstract
Loading... -
+
P2.07-023 - Safety of Immune Checkpoint Inhibitors in Patients with Preexisting Autoimmune Disease
09:30 - 09:30 | Presenter: Margaux Geier | Author(s): A. Tison, G. Quéré, L. Misery, T. Lesimple, M. Marcq, S. Martinez, F. Brunet-Possenti, S. Mansard, N. Beneton, M. Lambert, C. Rogé, O. Zehou, F. Aubin, S. Maanaoui, C. Scalbert, D. Giacchero, N. Kramkimel, F. Skowron, A. Pham-Ledard, D. Cornec, M. Kostine
- Abstract
Loading... -
+
P2.07-024 - Real-World Data of Nivolumab for Previously Treated Non-Small Cell Lung Cancer Patients in Japan: A Multicenter Retrospective Cohort Study
09:30 - 09:30 | Presenter: Daichi Fujimoto | Author(s): H. Yoshioka, Yuki Kataoka, Y.H. Kim, K. Tomii, T. Ishida, M. Hirabayashi, S. Hara, M. Ishitoko, Y. Fukuda, M.H. Hwang, N. Sakai, M. Fukui, H. Nakaji, T. Hirai
- Abstract
Loading... -
+
P2.07-025 - Increased Antitumor Response to Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Song Ee Park | Author(s): Y. Kim, H.K. Kim, H. Lee, J.H. Cho, S.W. Lim, S. Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn, Jong-Mu Sun
- Abstract
Loading... -
+
P2.07-026 - Nivolumab in Non-Small Cell Lung Cancer (NSCLC): Facing the Reality
09:30 - 09:30 | Presenter: Sivan Shamai | Author(s): O. Merimsky
- Abstract
Loading... -
+
P2.07-027 - Efficacy and Safety of Nivolumab Therapy for Advanced NSCLC in the Expanded Access Named Patient Program in Taiwan
09:30 - 09:30 | Presenter: Bin-Chi Liao | Author(s): C. Chiang, P. Chen, Y. Shen, W. Chen, J. Hung, K. Rau, C. Lai, C. Chen, Y. Kuo, Y. Tsai, S. Wu, C. Lin, Yu-Feng Wei, M. Wu, S. Tsao, T.C. Tsao, C. Ho, Y. Feng, C. Tsao, M. Lin, I. Chong, T. Hsia, N. Chu, Y. Chen, C. Yu, James Chih-Hsin Yang
- Abstract
Loading... -
+
P2.07-028 - Efficacy and Safety of Nivolumab in Non-Small Cell Lung Cancer Patients Who Relapse after Thoracic Radiotherapy
09:30 - 09:30 | Presenter: Teppei Yamaguchi | Author(s): Y. Oya, Y. Kagawa, H. Furuta, N. Watanabe, J. Shimizu, Y. Horio, T. Uemura, S. Morikawa, K. Imaizumi, T. Hida
- Abstract
Loading... -
+
P2.07-029 - CheckMate 169: Safety/Efficacy of Nivolumab in Canadian Pretreated Advanced NSCLC (including Elderly and PS 2) Patients
09:30 - 09:30 | Presenter: Rosalyn J. Juergens | Author(s): Q. Chu, J. Rothenstein, F. De Angelis, S. Banerji, K. Marquis, D. Sauciuc, P. Begin, N. Finn, Vera Hirsh, A. Faghih, J. Yun, A. Li, A. Acevedo, L. Musallam, P.K. Cheema
- Abstract
Loading... -
+
P2.07-030 - Real Life Second-Line Nivolumab in Advanced Non-Small-Cell-Lung Cancer: A French Observational Multicenter Study of 259 Patients
09:30 - 09:30 | Presenter: Margaux Geier | Author(s): R. Descourt, G. Quéré, R. Corre, G. Leveiller, R. Lamy, E. Goarant, J. Bizec, C. Bernier, F. Couturaud, G. Robinet
- Abstract
Loading... -
+
P2.07-031 - Relationship between Clinical Factors and the Expression of Programmed Death Ligand 1 in Lung Cancer
09:30 - 09:30 | Presenter: Yasuhiro Kato | Author(s): K. Watanabe, J. Kashima, K. Hashimoto, A. Fukuda, A. Mitsuhashi
- Abstract
Loading... -
+
P2.07-032 - Outcomes of Nivolumab in Metastatic NSCLC Patients via the Access Program Across Multiple Tertiary Oncology Centres.
09:30 - 09:30 | Presenter: Kenneth Obyrne | Author(s): K.E. Roberts, R. Mason, D. Vagenas, Z. Lwin, B. Hughes, V. Jain
- Abstract
Loading... -
+
P2.07-033 - Anti-PD1-Induced Rotator Cuff Injury: A Case Series
09:30 - 09:30 | Presenter: Kenneth Obyrne | Author(s): K.E. Roberts, Q. Tran, P. Eliadis, B. Hughes
- Abstract
Loading... -
+
P2.07-034 - Health Status in Patients with Small-Cell Lung Cancer Treated with Nivolumab Alone or Combined with Ipilimumab: CheckMate 032
09:30 - 09:30 | Presenter: D. Ross Camidge | Author(s): A. Ardizzoni, A.F. Farago, A. Atmaca, Emiliano Calvo, F. Taylor, B. Bennett, G. Selvaggi, A. Pieters, J.R. Penrod, Yong Yuan
- Abstract
Loading... -
+
P2.07-035 - Correlation Between Immune-Related Adverse Events and Efficacy in Non-Small Cell Lung Cancer Treated with Nivolumab
09:30 - 09:30 | Presenter: Koichi Sato | Author(s): H. Akamatsu, M. Eriko, S. Sakaki, K. Kanai, A. Hayata, N. Tokudome, K. Akamatsu, Y. Koh, H. Ueda, M. Nakanishi, Nobuyuki Yamamoto
- Abstract
Loading... -
+
P2.07-036 - Appropriate Use of Immune Checkpoint Inhibitors in Advanced NSCLC: Effectiveness of Unique Case-Based Education on Clinical Decision-Making
09:30 - 09:30 | Presenter: Tara Herrmann | Author(s): E. Hamarstrom, H. Kadkhoda, L. Wiggins, M.L. Johnson, J. Weiss
- Abstract
Loading... -
+
P2.07-037 - Developing a Predictive Clinical Outcome Model for Advanced Non-Small Cell Lung Cancer Patients
Receiving Nivolumab09:30 - 09:30 | Presenter: Wungki Park | Author(s): D. Kwon, D. Saravia, A. Desai, J. Warsch, F. Vargas, M. El Dinali, R. Elias, Y.K. Chae, D.W. Kim, S. Warsch, A. Ishkanian, C. Ikpeazu, R. Mudad, Gilberto Lopes, M. Jahanzeb
- Abstract
Loading... -
+
P2.07-038 - Thyroid Dysfunction Arising During KEYNOTE-001 Associated with Improved Efficacy of Pembrolizumab in NSCLC Patients at UCLA
09:30 - 09:30 | Presenter: Aaron Lisberg | Author(s): K. Bornazyan, J. Madrigal, J.L. Bui, J. Carroll, C. Adame, J. Hunt, H. Lu, Z. Noor, A. Cummings, Jonathan W. Goldman, Edward Brian Garon
- Abstract
Loading... -
+
P2.07-039 - Nivolumab Experience in Patients with Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC) in Toledo, Spain
09:30 - 09:30 | Presenter: Antonio Irigoyen Medina | Author(s): E. Martinez Moreno, K. Martinez Barroso, M. Borregon Rivilla, R. Alvarez Cabellos, J.D. Cardenas, J. Andrade Santiago, I. Burgueño Lorenzo, B. Trujillo Alba, J.I. Chacon Lopez-Muñiz
- Abstract
Loading... -
+
P2.07-040 - Pre-Treatment Tumor Volume in Non-Small Cell Lung Cancer (NSCLC) as a Predictor of Response to PD-1 Inhibitors
09:30 - 09:30 | Presenter: Misako Nagasaka | Author(s): M. Crosby, N. Thummala, J. Abrams, A. Sukari
- Abstract
Loading... -
+
P2.07-041 - Immuno-Related Cutaneous Adverse Events (IRcutAEs) in Patients (P) with Advanced NSCLC: A Single-Institution Prospective Study
09:30 - 09:30 | Presenter: Enric Carcereny | Author(s): A. Boada, R. Blanco, R. Marsé, N. Rivera, Margarita Majem, J. Terrasa, Y. García, J. Coves, A. Estival, E. Dalmau, L. Vila, P. Riera, T. Morán
- Abstract
Loading... -
+
P2.07-042 - Feasibility Study of Nivolumab and Docetaxel in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Tsuneo Shimokawa | Author(s): Y. Nakamura, S. Iwasawa, K. Miyazaki, T. Yamanaka, Y. Takiguchi, Hiroaki Okamoto
- Abstract
Loading... -
+
P2.07-043 - Efficacy and Safety of Anti-PD-1 Antibody as the First Line Treatment in Elderly Patient with Advanced Lung Squamous Cell Carcinoma: A Case Report
09:30 - 09:30 | Presenter: Hua min Shi | Author(s): F.Y. Xing
- Abstract
Loading... -
+
P2.07-044 - Thyroid Disfunction in Advanced NSCLC Patients Treated with Nivolumab out of Clinical Trial: A Real-World Data Analysis
09:30 - 09:30 | Presenter: Ramon Palmero | Author(s): J.C. Ruffinelli, E. Alanya, J.A. Marin, M. Ferrer, M. Jove, C. Mesia, M. Arellano, I. Brao, F. Cardenal, I. Peiro, Ernest Nadal
- Abstract
Loading... -
+
P2.07-045 - A Retrospective Analysis of Nivolumab-Related Pneumonitis in Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Presenter: Shuhei Tsujino | Author(s): T. Ikeda, Hirokazu Taniguchi, M. Shimada, H. Gyoutoku, H. Senju, H. Yamaguchi, K. Nakatomi, Minoru Fukuda, H. Mukae
- Abstract
Loading... -
+
P2.07-046 - Nivolumab Exerts Remarkable Antitumor Activity in NSCLC After an Immune-Modulating Biochemotherapy Regimen
09:30 - 09:30 | Presenter: Pierpaolo Correale | Author(s): P. Pastina, V. Nardone, C. Botta, S. Croci, D. Davì, P. Tini, G. Battaglia, L. Sebaste, T. Carfagno, S.F. Carbone, V. Ricci, R. Giannicola, P. Tagliaferri, L. Pirtoli
- Abstract
Loading... -
+
P2.07-047 - Poor Performance Status and BRAF Mutation Predict Grade 3-5 Immune-Related Adverse Events in Pts with Advanced NSCLC
09:30 - 09:30 | Presenter: Yan Wang | Author(s): Jinpeng Shi, W. Li, G. Gao, Shengxiang Ren, Caicun Zhou
- Abstract
Loading... -
+
P2.07-048 - Immunotherapy vs. Targeted Therapy - Who Wins? A Case Series
09:30 - 09:30 | Presenter: Inbar Finkel | Author(s): Nir Peled
- Abstract
Loading... -
+
P2.07-049 - Early Clinical Predictors of Progressive Disease or Non-Response to PD-1/PD-L1 Inhibitors in Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: David P Walder | Author(s): R. Kumar, M. Brandao, N. Joharatnam, J. Pealing, A.R. Minchom, C. Milner-Watts, S.Y. Moorcraft, F. Turkes, N. Yousaf, J. Bhosle, Sanjay Popat, Mary Obrien
- Abstract
Loading... -
+
P2.07-050 - Impact of Steroid Use for Immune Related Adverse Events on Outcomes in Non-Small Cell Lung Cancer (NSCLC) Treated with Checkpoint Inhibitors
09:30 - 09:30 | Presenter: Neil J Shah | Author(s): W.J. Kelly, B. Ma, J. Puthiamadathil, M.T. Serzan, Y. Zhou, M. Tan, D. Subramaniam, Giuseppe Giaccone, S.V. Liu
- Abstract
Loading... -
+
P2.07-051 - Immune Checkpoint Associated Cardiotoxicity: An Update
09:30 - 09:30 | Presenter: Zin War Mynt | Author(s): A. Chauhan, S. Arnold, B. Grant, L.B. Anthony
- Abstract
Loading... -
+
P2.07-052 - Detection of KRAS Mutation in Blood Predicts Favorable Response to Immunotherapy in NSCLC
09:30 - 09:30 | Presenter: Martin Frederik Dietrich | Author(s): B. Hunis, Luis E Raez
- Abstract
Loading... -
+
P2.07-053 - A Case of Small Cell Lung Cancer Complicated During Nivolumab Administration as Second Line Treatment for Squamous Cell Lung Cancer
09:30 - 09:30 | Presenter: Tomoki Kimura | Author(s): Y. Kondoh, K. Kataoka, T. Matsuda, T. Yokoyama
- Abstract
Loading... -
+
P2.07-054 - Cost-Effectiveness of Pembrolizumab as First-Line Therapy for Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Pedro Aguiar Jr | Author(s): M. Georgieva, J.P. Lima, B. Haaland, Gilberto Lopes
- Abstract
Loading... -
+
P2.07-055 - Indirect Comparison between Immune-Checkpoint Inhibitors for 2nd Line Non-Small Cell Lung Cancer – a Network Meta-Analysis
09:30 - 09:30 | Presenter: Pedro Aguiar Jr | Author(s): P. Tan, B. Haaland, Gilberto Lopes
- Abstract
Loading... -
+
P2.07-056 - SAKK 16/14 – Perioperative Anti-PD-L1 Antibody Durvalumab in Patients with Stage IIIA(N2) Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Sacha I Rothschild | Author(s): A. Zippelius, Spasenija Savic, M. Gonzalez, Walter Weder, A. Xyrafas, C. Rusterholz, M. Pless
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.07-058 - First-In-Human Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, for Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Julie R Brahmer | Author(s): M.L. Johnson, M.M. Awad, A. Rajan, A.J. Allred, R.E. Knoblauch, E. Zudaire, M.V. Lorenzi, R. Hassan
- Abstract
Loading... -
+
P2.07-059 - Phase I Trial of Gene Mediated Cytotoxic Immunotherapy (GMCI) for Malignant Pleural Effusion (MPE) and Malignant Pleural Mesothelioma (MPM)
09:30 - 09:30 | Presenter: Daniel H. Sterman | Author(s): A.R. Haas, S. Metzger, L.K. Aguilar, E. Aguilar-Cordova, A. Manzanera, G. Gomez, S. Albelda, E. Alley, T. Evans, R.B. Cohen, Joshua Michael Bauml, Corey J Langer, C. Aggarwal
- Abstract
Loading... -
+
P2.07-060 - Response Assessment and Subgroups Analysis According to the Lung Immune Prognostic Index (LIPI) for Immunotherapy in Advanced NSCLC Patients
09:30 - 09:30 | Presenter: Laura Mezquita | Author(s): E. Auclin, Roberto Ferrara, C. Caramella, M. Charrier, J. Remon, David Planchard, S. Ponce, Luis Paz-Ares, J. Lahmar, L. Leroy, C. Audigier-Valette, J. Zeron-Medina, Pilar Garrido, G. Zalcman, Julien Mazieres, J. Adam, N. Chaput, J. Soria, Benjamin Besse
- Abstract
Loading... -
+
P2.07-061 - Nivolumab for Patients with Non-Small Cell Lung Carcinoma in Patients with Progression to One or More Lines of Chemotherapy in Mexican Population
09:30 - 09:30 | Presenter: Jeronimo Rafael Rodriguez-Cid | Author(s): D. Bonilla-Molina, L. Martínez-Barreda, J. Díaz-Rico, P. Arellanes-Herrera, E. Del Olmo Gil, J.C. Chagoya-Bello, J.A. Alatorre Alexander
- Abstract
Loading... -
+
P2.07-062 - PIVOT-02: Phase 1/2 Study of NKTR‐214 and Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumor Malignancies
09:30 - 09:30 | Presenter: Vassiliki A Papadimitrakopoulou | Author(s): N.M. Tannir, C. Bernatchez, C.L. Haymaker, S.E. Bentebibel, B.D. Curti, M.K.K. Wong, I. Gergel, M.A. Tagliaferri, J. Zalevsky, U. Hoch, S. Aung, M. Imperiale, D.C. Cho, S.S. Tykodi, I. Puzanov, H.M. Kluger, M.E. Hurwitz, P. Hwu, M. Sznol, A. Diab
- Abstract
Loading... -
+
P2.07-062a - Single Institutional Experience of the Use of PD-1 Inhibitors to Non-Small Cell Lung Cancer Patients with Preexisting Autoimmune Diseases
09:30 - 09:30 | Presenter: Mehmet Altan | Author(s): F. Fossella, Jianjun Zhang, L. Lacerda Landry, E. Roarty, J. Roth, Stephen Swisher, John V Heymach
- Abstract
Loading... -
+
P2.07-062b - DNA Damage Repair Targeting Upregulates PD-L1 Level and Potentiates the Effect of PD-L1 Blockade in Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Triparna Sen | Author(s): L. Chen, B..L. Rodriguez, C.M. Gay, L. Li, Y. Yang, Y. Fan, B. Glisson, J. Wang, H. Piwnica-Worms, Julien Sage, John V Heymach, Don Lynn Gibbons, L.A. Byers
- Abstract
No abstract available for this presentation
-
+
P2.07-062c - A Phase II Study of BGB324 in Combination with Pembrolizumab in Patients with Previously Treated Advanced Lung Adenocarcinoma
09:30 - 09:30 | Presenter: M. Yule | Author(s): K. Wnuk-Lipinska, K. Davidsen, M. Blø, A. Engelsen, J. Kang, L. Hodneland, K. Aguilera, E. Milde Nævdal, A. Boniecka, O. Straume, S. Chouaib, R.A. Brekken, G. Gausdal, J. Lorens
- Abstract
No abstract available for this presentation
-
+
P2.08 - Locally Advanced Nsclc
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Locally Advanced NSCLC
-
+
P2.08-001 - Hand Grip Strength Is an Independent Prognostic Factor for Mortality in Patients with NSCLC Undergoing Radiotherapy
09:30 - 09:30 | Presenter: Dirk K De Ruysscher | Author(s): Chris Burtin, J. Bezuidenhout, M.A. Spruit
- Abstract
Loading... -
+
P2.08-002 - A Nomogram for Predicting Underlying Beneficiaries for Resectable IIIA/N2 NSCLC Patients
09:30 - 09:30 | Presenter: Chao Zhang | Author(s): Y. Chen, H. Zhai, X. Yang, Yi-Long Wu, W. Zhong
- Abstract
Loading... -
+
P2.08-003 - An Audit of Concurrent Chemoradiotherapy for Non-Small Cell Lung Cancer at the Leeds Cancer Centre (LCC)
09:30 - 09:30 | Presenter: Katy Louise Clarke | Author(s): F. Sun, O. Coen, E. Appleton, A. Zeniou, K.N. Franks, M. Snee, P. Dickinson, P. Jain
- Abstract
Loading... -
+
P2.08-004 - Pathologic Complete Response as an Independed Prognostic Factor in Patients with Locally Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Waldemar Schreiner | Author(s): W. Dudek, R. Fietkau, H. Sirbu
- Abstract
Loading... -
+
P2.08-005 - Salvage Lung Surgery Following Definitive Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Waldemar Schreiner | Author(s): W. Dudek, R. Fietkau, H. Sirbu
- Abstract
Loading... -
+
P2.08-006 - Immunological Biomarkers Characterization in Locally Advanced Non-Small Cell Lung Cancer Treated with Concurrent Chemo-Radiotherapy
09:30 - 09:30 | Presenter: Ernest Nadal | Author(s): M. Saigi, N. Baixeras, A. Rullan, M.A. Bergamino Sirvén, A. Navarro-Martin, M. Arnaiz, J.C. Ruffinelli, C. Mesia, Ramon Palmero, S. Padrones, F. Cardenal, Montse Sanchez-Cespedes
- Abstract
Loading... -
+
P2.08-007 - Five-Year Results of Concurrent Chemotherapy and Isotoxic Radiotherapy Dose-Escalation with IMRT in Stage III NSCLC (NCT01166204)
09:30 - 09:30 | Presenter: Dirk K De Ruysscher | Author(s): B. Reymen, G. Bootsma, Anne-Marie C. Dingemans, W. Geraedts, C. Pitz, W. Van Elmpt, M. Oellers, A. Van Baardwijk, R. Wanders, J. Van Loon
- Abstract
Loading...
-
+
P2.09 - Mesothelioma
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Mesothelioma
-
+
P2.09-001 - Effects of Tumor Burden Reduction on Survival in Epithelioid Pleural Mesothelioma
09:30 - 09:30 | Presenter: Aaron S. Mansfield | Author(s): T. Peikert, N. Vogelzang, J. Symanowski
- Abstract
Loading... -
+
P2.09-001a - TNM or Tumor Volume for Predicting Prognosis in Malignant Pleural Mesothelioma: Still an Open Debate
09:30 - 09:30 | Presenter: Marina Chiara Garassino | Author(s): M. Imbimbo, C. Proto, S. Mallone, D. Signorelli, F.G. Greco, G. Calareso, L. Botta, G. Lo Russo, M. Vitali, G. Corrao, G. Galli, M. Ganzinelli, N. Zilembo, Ugo Pastorino, A. Trama
- Abstract
Loading... -
+
P2.09-002 - Prevalence and Survival of Malignant Pleural Mesothelioma Patients Treated in a Single Brazilian Cancer Center
09:30 - 09:30 | Presenter: V.C. Cordeiro De Lima | Author(s): João Navarro Reolon, A.B.A. Costa, G. Venturi, J.L. Gross, Helano Carioca Freitas, D.B. Sales
- Abstract
Loading... -
+
P2.09-003 - Dissecting the Immune Environment in Malignant Pleural Mesothelioma: Results from a Prospective Assessment
09:30 - 09:30 | Presenter: Silvia Novello | Author(s): C. Riganti, M. Pradotto, L. Righi, C. Marchiò, E. Capelletto, C. Buttigliero, L. Costardi, J. Kopecka, P. Bironzo, Enrico Ruffini, Giorgio Vittorio Scagliotti
- Abstract
Loading... -
+
P2.09-004 - PD-L1 Protein Expression Is Negative Prognostic Factor in Malignant Pleural Mesothelioma in Central Europe
09:30 - 09:30 | Presenter: Luka Brcic | Author(s): Marko Jakopovic, I. Kern, K. Mohorcic, S. Seiwerth, Michael Grusch, M. Rajer, A. Buder, T. Klikovits, V. Laszlo, B. Dome, B. Hegedus, W. Klepetko, V. Kolek, Robert Pirker, Mir Alireza Hoda, Martin Filipits
- Abstract
Loading... -
+
P2.09-005 - The C-reactive Protein/Albumin Ratio is a Novel Significant Prognostic Factor in Patients with Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: Shinkichi Takamori | Author(s): Gouji Toyokawa, T. Tagawa, F. Kinoshita, Yuka Kozuma, T. Matsubara, Naoki Haratake, Takaki Akamine, F. Hirai, M. Takenoyama, Y. Ichinose, Y. Maehara
- Abstract
Loading... -
+
P2.09-005a - Clinical Characteristics of Early Stage, Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: Kozo Kuribayashi | Author(s): Yoshiki Negi, Y. Koda, K. Mikami, T. Minami, T. Yokoi, S. Hasegawa, T. Kijima
- Abstract
Loading... -
+
P2.09-006 - FISH Analysis of p16 and BAP1 Immunohistochemistry for the Diagnosis of Mesothelioma
09:30 - 09:30 | Presenter: Kenzo Hiroshima | Author(s): D. Wu, T. Yusa, D. Ozaki, E. Koh, Yasuo Sekine, R. Haba, K. Washimi, K. Nabeshima, T. Tsujimura
- Abstract
Loading... -
+
P2.09-007 - Pleural Biopsy in Patients Suspected of Malignant Pleural Mesothelioma Consecutive 377 Cases
09:30 - 09:30 | Presenter: Masaki Hashimoto | Author(s): T. Nakamichi, A. Fukuda, A. Kuroda, T. Takuwa, S. Matsumoto, N. Kondo, T. Tsujimura, S. Hasegawa
- Abstract
Loading... -
+
P2.09-008 - Usefulness of Immunohistochemistry in the Differential Diagnosis of Epithelioid Mesothelioma and Lung Squamous Cell Carcinoma
09:30 - 09:30 | Presenter: Kei Kushitani | Author(s): Vishwa Jeet Amatya, Y. Okada, Y. Katayama, A.S. Mawas, Y. Miyata, Morihito Okada, K. Inai, T. Kishimoto, Y. Takeshima
- Abstract
Loading...
-
+
P2.10 - Nursing/Palliative Care/Ethics
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Nursing/Palliative Care/Ethics
-
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.10-003 - The Deterioration and Prognostic Value of Functional Capacity in Patients with Lung Cancer: A Systematic Review
09:30 - 09:30 | Presenter: Laerke Winther | Author(s): Morten Quist
- Abstract
Loading... -
+
P2.10-004 - Efficacy and Safety of Viscum Album (Helixor M) to Treat Malignant Pleural Effusion in Patients with Advanced Lung Cancer
09:30 - 09:30 | Presenter: Yun-Gyoo Lee | Author(s): I. Jung, S. Lee
- Abstract
Loading... -
+
P2.10-005 - Overall Survival of Lung Cancer Patients with Brain Metastases in a Developing Country
09:30 - 09:30 | Presenter: Tomi Kovacevic | Author(s): B. Zaric, D. Bokan
- Abstract
Loading... -
+
P2.10-006 - Prognostic Factors of Mortality and Recurrence of Malignant Pleural Effusion in High-Risk Tumors According to the LENT Score Study
09:30 - 09:30 | Presenter: Fernando Conrado Abrão | Author(s): M.C.D. Oliveira, G.G. Viana, I.R. Abreu, R. Younes, C. Marciano
- Abstract
Loading... -
+
P2.10-007 - Quality of Life across Various Treatment Lines in Metastatic Lung Cancer Patients
09:30 - 09:30 | Presenter: Aseem Rai Bhatnagar | Author(s): P. Kumbhaj, R. Bhandari, R. Sharma
- Abstract
Loading...
-
+
P2.11 - Patient Advocacy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Patient Advocacy
-
+
P2.11-001 - Evaluation of a Cultural Notebook of Self-Expression and Follow-Up Among Patients with Lung Cancer in French Polynesia
09:30 - 09:30 | Presenter: Eric Parrat | Author(s): D. Lutringer-Magnin, P. Barthe-Vonsy, M. Giroud
- Abstract
Loading... -
+
P2.11-002 - To Live and Work with Lung Cancer: Coping Strategies of a Stage 4 Patient
09:30 - 09:30 | Presenter: Satoko Kono | Author(s): T. Yamaoka
- Abstract
Loading...